TransCode Therapeutics Price Chart
TransCode Therapeutics Volume Chart
TransCode Therapeutics Market Segments
Overnight
*No Trades in Segment
After Hours
+0.00(+0.00%)
| Open | $5.47 |
|---|---|
| Close | $5.47 |
| Low | $5.47 |
| Low Change | 0.00 (0.00%) |
| High | $5.47 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 511 |
| Dollar Volume | $2.80K |
Regular Trading Hours
+0.37(+7.05%)
| Open | $5.18 |
|---|---|
| Close | $5.54 |
| Low | $5.02 |
| Low Change | -0.16 (-3.00%) |
| High | $6.00 |
| High Change | +0.83 (+15.94%) |
| Range | $0.98 |
| Volume | 33.2K |
| Dollar Volume | $183.93K |
Premarket
*No Trades in Segment
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
+0.03(+0.57%)
| Open | $5.30 |
|---|---|
| Close | $5.33 |
| Low | $5.30 |
| Low Change | 0.00 (0.00%) |
| High | $5.50 |
| High Change | +0.20 (+3.77%) |
| Range | $0.20 |
| Volume | 3.397K |
| Dollar Volume | $18.11K |
Premarket Yesterday
*No Trades in Segment
TransCode Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $5.25 |
|---|---|
| 10 Day Moving Average (SMA10) | $5.35 |
| 20 Day Moving Average (SMA20) | $5.59 |
| 50 Day Moving Average (SMA50) | $7.20 |
| 100 Day Moving Average (SMA100) | $8.42 |
| 200 Day Moving Average (SMA200) | $9.26 |
TransCode Therapeutics Statistics
| Average Volume (30 Days) | — |
|---|---|
| P/E Ratio (Current) | — |
| EPS (Current) | — |
| Dividend Yield | — |
| Free Cash Flow | — |
| Cash Ratio | — |
| Current Ratio | — |
| Quick Ratio | — |
| Debt to Equity | — |
| Enterprise Value | — |
| EV to EBITDA | — |
| EV to Sales | — |
| Price to Book | — |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | — |
| Return on Equity | — |
TransCode Therapeutics Stock Splits
There have been 4 stock splits for TransCode Therapeutics (RNAZ). The last reverse stock split occured on May 15, 2025 and reduced the outstanding shares at a ratio of 28:1.
| Date | Type | Ratio |
|---|---|---|
| May 15, 2025 | Reverse | 28:1 |
| Dec 4, 2024 | Reverse | 33:1 |
| Jan 16, 2024 | Reverse | 40:1 |
| May 23, 2023 | Reverse | 20:1 |
TransCode Therapeutics Dividends
There have been no dividends for TransCode Therapeutics (RNAZ).